The effects of the guanosine diphosphate esters of 4-deoxy-4-fluoro-D-mannose (GDP-4FMan) and 4-deoxy-D-mannose (GDP-4dMan) on reactions of the dolichol pathway in chick-embryo cell microsomal membranes were investigated by studies with chick-embryo cell microsomal membranes in vitro and in babyhamster kidney (BHK) cells in vivo. Each nucleotide sugar analogue inhibited lipid-linked oligosaccharide biosynthesis in a concentration-dependent manner. GDP-4FMan blocked in vitro the addition of mannose to Dol-PP-(GlcNAc)2Man from GDP-Man (where Dol represents dolichol), but did not interfere with the formation of Dol-P-Man, Dol-P-Glc and Dol-PP-(GlcNAc)2. Although GDP-4FMan and Dol-P-4FMan were identified as metabolites of 4FMan in BHK cells labelled with [1-'4C]4FMan, GDP-4FMan was a very poor substrate for GDP-Man:Dol-P mannosyltransferase and Dol-P-4FMan could only be synthesized in vitro if the chick-embryo cell membranes were primed with Dol-P. It therefore appears that the inhibition of lipid-linked oligosaccharide formation in BHK cells treated with 4FMan [Grier & Rasmussen (1984) J. Biol. Chem. 259, 1027-1030] is due primarily to a blockage in the formation of Dol-PP-(GlcNAc)2Man2 by GDP-4FMan. In contrast, GDP-4dMan was a substrate for those mannosyltransferases that catalyse the transfer of the first five mannose residues to Dol-PP-(GlcNAc)2. In addition, GDP-4dMan was a substrate for GDP-Man: Dol-P mannosyltransferase, which catalysed the formation of Dol-P-4dMan. As a consequence of this, the formation of Dol-P-Man, Dol-P-Glc and Dol-PP-(GlcNAc)2 may be inhibited through competition for Dol-P. In BHK cells treated with 10 mM-4dMan, Dol-PP-(GlcNAc)2Man9 was the major lipid-linked oligosaccharide detected. Nearly normal extents of protein glycosylation were observed, but very little processing to complex oligosaccharides occurred, and the high-mannose structures were smaller than in untreated cells.
INTRODUCTION
Protein glycosylation of asparagine-linked glycoproteins is a complex series of events. The first stage involves the assembly of the tetradecasaccharide precursor Glc3Man9(GlcNAc)2 on a dolichol diphosphate carrier (Kornfeld & Kornfeld, 1985) . Then, after its transfer to protein, this oligosaccharide is processed to the high-mannose and complex structures characteristic of mature glycoproteins (Kornfeld & Kornfeld, 1985) . Previous studies have shown that analogues of glucose and mannose can interfere with protein glycosylation (Schwarz & Datema, 1982a) . One class of compounds, which includes 2-deoxy-D-glucose, 2-amino-2-deoxy-Dglucose, 2-deoxy-2-fluoro-D-glucose and 2-deoxy-2-fluoro-D-mannose, inhibits the assembly of the dolichol diphosphate precursor oligosaccharide (Schwarz & Datema, 1982a) . A second class of compounds, which includes bromoconduritol, (N-methyl-) 1 -deoxynojirimycin, castanospermine, swainsonine and 1-deoxymannojirimycin (Schwarz & Datema, 1984; Fuhrmann et al., 1984) , inhibits the glycosidases involved in the processing of the protein-linked oligosaccharide. With the exception of 2-amino-2-deoxy-D-glucose compounds of the first class are metabolized to their respective guanosine and uridine nucleoside diphosphate derivatives (Schwarz & Datema, 1982a) , and it is these metabolites that are the actual inhibitory agents. These sugar analogues all contain modifications at the C-2 position. In recent years several analogues of D-mannose containing C-3 and C-4 substituents have been synthesized (Rasmussen, 1980; Rasmussen et al., 1983; Scensny et al., 1983) . Two of these mannose analogues, 3-deoxy-3-fluoro-D-mannose (3FMan) and 4-deoxy-4-fluoro-Dmannose (4FMan), have been shown (Grier & Rasmussen, 1983) to be metabolized in yeast to their Abbreviations used: 4FMan, 4-deoxy-4-fluoro-D-mannose; 4dMan, 4-deoxy-D-mannose; Dol-P, dolichyl monophosphate; Dol-PP, dolichyl pyrophosphate; CM, chloroform/methanol (2:1, v/v); CMW, chloroform/methanol/water (10:10:3, by vol.); BHK cells, baby-hamster kidney cells.
§ To whom correspondence should be addressed. Vol. 248 523 respective 6-phosphates, 1,6-bisphosphates and guanosine diphosphate esters. Furthermore 4FMan was found (Grier & Rasmussen, 1984) to interfere with the glycosylation of viral G-protein in vesicular-stomatitisvirus-infected BHK cells as a consequence of depleted intracellular pools of Dol-PP-(GlcNAc)2Man9Glc3. To investigate further the inhibitory effects of 4FMan on protein glycosylation we have synthesized the guanosine diphosphate ester of 4FMan and of the related 4dMan and tested their effects on reactions of the dolichol pathway in vitro. In addition, further studies in BHK cells on the metabolism of 4FMan and the effects of 4dMan on protein glycosylation are presented.
EXPERIMENTAL Materials 4FMan and 4dMan were synthesized as described elsewhere . The 1-phosphates of 4FMan and 4dMan were prepared by the MacDonald (1961) procedure. GDP-4FMan and GDP-4dMan were prepared by the procedure described for the synthesis of GDP-2FMan (McDowell et al., 1985) . Krag & Robbins (1977) as described by Schwarz & Datema (1982b) . This preparation, containing 15-20 mg of protein/ml, was either used directly or treated to complete the synthesis of partially assembled lipid-linked oligosaccharides as described previously (McDowell et al., 1985) .
Membranes enriched in Dol-PP-(GlcNAc)2 were prepared by incubating the membranes with 22 ,sM-UDPGlcNAc (Datema & Schwarz, 1978) . Cell-free synthesis of lipid-linked oligosaccharides was performed as described by Schwarz & Datema (1982b) . Where appropriate, ATP (0.14 mM) and 2,3-dimercaptopropanol (5 mM) (Faltynek et al., 1981) were included in the cellfree assays to prevent degradation of sugar nucleotides. Dol-P (0.3 mg/ml final concentration) was added as a suspension in 0.2% (v/v) Triton X-100 (0.017% final concentration in the assay mixture).
Separation methods
Thin-layer plates ofsilica gel G-60 and paper chromatograms (Whatman 3MM paper) were developed in one of the following solvent systems (all solvent ratios are by volume): A, chloroform/methanol/conc. NH3/water (65:35:4:4); B, ethyl acetate/pyridine/water (8:2: 1); C, chloroform/methanol/water (65:25:4); D, propan-1-ol/water (7:3); E, chloroform/methanol/acetic acid/ water (25:15:4:2). After development the thin-layer chromatograms were either scanned for radioactivity with a Berthold LB 2842 automatic scanner or the silica gel was scraped off the plates in 1 cm portions for subsequent measurement in a liquid-scintillation counter. Paper chromatograms were cut into 1 cm strips before radioactivity counting.
Columns (1 cm x 150 cm or 1 cm x 105 cm) of Bio-Gel P4 (-400 mesh), eluted with water containing 0.2 % NaN3 or with 0.1 M-pyridine/acetate buffer, pH 5.0, were used for the separation of oligosaccharides derived from lipid-linked oligosaccharides by mild acid hydrolysis as well as those released from Pronase-digested glycoproteins by treatment with endo-N-acetylglucosaminidase H.
Ion-exchange chromatography of lipid-linked oligosaccharides was carried out with columns of DEAE cellulose (acetate form) equilibrated with CMW. Monophosphate-containing material was eluted with a solution of 2 mM-ammonium acetate in CMW, and diphosphatecontaining material was eluted with 20 mm-or 200 mmammonium acetate in CMW.
Other procedures
The mild acid hydrolysis of lipid-linked oligosaccharides and endo-N-acetylglucosaminidase H treatment have been described elsewhere (Schwarz & Datema, 1982a; Grier & Rasmussen, 1984 (Grier & Rasmussen, 1983) . BHK 21 cells were cultivated and maintained as before (Grier & Rasmussen, 1984) . Incorporation of label into the CM and CMW extracts and the lipid-free residue was determined. Labelled mannose incorporation into lipid-linked oligosaccharides soluble in CMW was strongly inhibited (by 90 %) by either nucleotide sugar analogue (Fig. lb) as was the incorporation into the residue fraction (Fig. lc) . However, the analogues exhibited differing effects on mannose incorporation into the CM extract (Fig. la) . GDP4dMan inhibited incorporation by 70 %, whereas GDP4FMan had little effect (Fig. la) . The reasons for these differences became apparent when the CM extracts from the incubations containing 150 #M inhibitor were examined by t.l.c. (solvent system A). In the control incubation ( Fig. 2a ) Dol-P-Man, Dol-PP-(GlcNAc)2Man, Dol-PP-(GlcNAc)2Man2 and Dol-PP-(GlcNAc)2Man3 (all identified by comparison with previously characterized reference compounds) were detected. In the presence of GDP-4FMan ( Fig. 2b ) a large Dol-P-Man peak was present together with Dol-PP-(GlcNAc)2Man and decreased amounts of Dol-PP-(GlcNAc)2Man2 and Dol-PP-(GlcNAc)2Man3. The (-) or -GDP4dMan (0). The assay mixtures were then extracted with CM and CMW (Schwarz & Datema, 1982b) , and the incorporation of radioactive label into (a) the CM extract, (b) the CMW extract and (c) the lipid-free residue was determined.
RESULTS

Effect
chromatogram of the incubation containing GDP4dMan ( Fig. 2c) was quite different. The amount of Dol-P-Man and each of the lipid-linked oligosaccharides was decreased. Quantitative determination of the individual peaks on each chromatogram gave the values shown in Table 1 . The fact that in the presence of GDP-4FMan the amounts of Dol-P-Man and Dol-PP-(GlcNAc)2Man were elevated while those of the other lipid-linked oligosaccharides were much diminished (Table 1) suggests that the transfer of the second mannose residue from GDP-Man is blocked by GDP-4FMan. Dol-PMan accumulates because no Dol-PP-(GlcNAc)2Man5 is available to act as an acceptor of the mannose residues from Dol-P-Man. The observation that GDP-4dMan drastically decreases the formation of all lipid species (Table 1) , especially Dol-P-Man, indicates that it may serve as an alternative substrate.
Vol. 248 525 (Fig. 3a) . Addition of exogenous Dol-P stimulated incorporation 5-fold. It is characteristic of deoxy sugars to have chromatographic mobilities greater than their parent compounds in this solvent system (McDowell et al., 1985) , and thus it can be inferred that the peak in the chromatogram is Dol-P4dMan. When the membranes were preincubated with UDP-GlcNAc to form a pool of Dol-PP-(GlcNAc)2, a second compound, with the mobility of a lipid-linked trisaccharide, was also present on the chromatogram (Fig. 3b) . This slower-moving compound is presumably Dol-PP-(GlcNAc)24dMan, indicating that 4dMan can at least replace the first mannose residue in lipid-linked oligosaccharides.
Under standard reaction conditions GDP-[14C]-4FMan gave no incorporation of label into either of the two lipid extracts. Incorporation of label was only observed if the membranes were first pretreated to complete partially synthesized lipid-linked oligosaccharides and then recovered by ultracentrifugation. It was also necessary to include 2,3-dimercaptopropanol + ATP in the incubation mixture to inhibit endogenous nucleotidases. Under these conditions incorporation was very low and a single radioactive peak with a mobility greater than that of Dol-P-Man was just discernible on t.l.c. (Fig. 3c) . However, addition of exogenous Dol-P stimulated incorporation, producing a more obvious peak on t.l.c. (Fig. 3d) (Fig. 4a) . Addition of GDP-Man resulted in the formation of large lipid-linked oligosaccharides (Fig. 4b ), which were also observed when GDP-Man and GDP-4dMan were present together (Fig. 4c) . When GDP-4dMan was used alone, however, an oligosaccharide with the properties of Man5(GlcNAc)2 was formed (Fig. 4d) . Thus it appears that 4dMan residues can replace each of the first five mannose residues that are derived directly from GDP-Man. It would also appear that 4dMan cannot be transferred further from Dol-P-4dMan. As a result trapping of Dol-P may occur. GDP-4FMan did not act as a substrate for the elongation of Dol-PP-(GlcNAc)2 (Figs. 4e and 4f ). The main peak in Fig. 4(e) is Man(GlcNAc)2, which accumulates in the presence of GDP-4FMan, as also shown in Fig. 2(b Figs. 3b and 4b) , showing that 4dMan residues can be incorporated into lipid-linked oligosaccharides at an early stage in the biosynthetic pathway, are taken into account, it would seem more appropriate to consider the compositions of the main peaks in Figs. 5(b) and 5(d) to be (Man + 4dMan)9(GlcNAc)2 (Fig. 5b) and (Man + 4dMan)9-GlcNAc and (Man+4dMan)7GlcNAc (Fig. Sd) .
Metabolism of 4FMan by BHK cells
To correlate the data obtained in vitro and in vivo for the mannose analogues it was desirable to investigate their metabolism in BHK cells. Such an investigation with yeast cells (Grier & Rasmussen, 1983) showed that 4FMan was metabolized to its 6-phosphate and GDP derivatives. BHK cells were labelled with [1-'4C]4FMan (43 ,tCi) for 240 min and then extracted to give aqueous, CM and CMW fractions. Analysis of the aqueous fraction (extracted with 4 mM-MgCl2) by paper chromatography (Fig. 6) , and chemical and enzymic reactivities (Table 3) indicated that 4FMan was metabolized to 4FMan-6-P and GDP-4FMan. Analysis of the CM fraction by t,l.c. (Figs. 7a-7c) indicated the presence of a radiolabelled product with the chromatographic properties expected for Dol-P-4FMan. This product was eluted from the silica and further characterized by DEAE-cellulose ion-exchange chromatography. Most of the label (75 %) could be eluted from the column with 2 mM-ammonium acetate in CMW, indicating the presence of a monophosphate derivative. Acid hydrolysis followed by paper-chromatographic analysis confirmed that 4FMan was the sugar moiety (Fig. 7d) . [1-14C]4dMan did not result in the accumulation of measurable amounts ofmetabolites. This is not surprising in view of the low efficiency with which 4-deoxy sugars are phosphorylated by hexokinase (Finch & Merchant, 1979) .
DISCUSSION
Previous studies (Schwarz & Datema, 1982a; McDowell et al., 1985) have shown that fluoro sugars can inhibit protein glycosylation by interfering with the assembly of the lipid-linked tetradecasaccharide precursor intermediate. In the case of 2dGlc and 2FMan the guanosine diphosphate esters are the actual inhibitory agents (Datema & Schwarz, 1978; McDowell et al., 1985) . In the present study the inhibitory effects of 4FMan towards protein glycosylation (Grier & Rasmussen, 1984) can also be attributed to the guanosine diphosphate ester. Specifically, GDP-4FMan was produced by BHK cells and found in vitro to inhibit the transfer of mannose from GDP-Man to Dol-PP-(GlcNAc)2Man. Interestingly, had no observable effect in vitro on the synthesis of Dol-P-Man in spite of the fact that Dol-P-4FMan was identified as a metabolite of 4FMan in BHK cells treated with the labelled sugar analogue. In contrast, Dol-P-Man formation is inhibited by GDP-2FMan owing to the formation of a Dol-P-sugar analogue derivative (McDowell et al., 1985) . One explanation for this difference is that GDP4FMan is a poor substrate for GDP-Man: Dol-P mannosyltransferase. Thus it was extremely difficult to detect Dol-P-4FMan formation from labelled GDP4FMan in vitro. The microsomal membranes had to be primed with Dol-P and the reaction was carried out in the presence of 2,3-dimercaptopropanol + ATP to inhibit endogenous phosphatases present in the membrane preparation (Faltynek et al., 1981) .
Unlike the 4-fluoro analogue, treatment of BHK cells with 10 mM-4dMan did not significantly decrease the extent of glycosylation of newly synthesized proteins. Subsequent processing of the oligosaccharides appeared to be abnormal, however. Decreased amounts ofendo-Nacetylglucosaminidase H-resistant chains and smaller high-mannose structures were present. The major lipidlinked oligosaccharide in BHK cells treated with 10 mm4dMan was Dol-PP-(GlcNAc)2Man9. Only a trace amount of Dol-PP-(GlcNAc)2Man9Glc3 was detected. Examination of the effects in vitro of GDP-4dMan on lipid-linked oligosaccharide biosynthesis provided a partial explanation of these observations. Dol-P-4dMan was readily formed in vitro when labelled GDP-4dMan was incubated with the microsomal membrane preparation. Likewise, when GDP-4dMan alone was incubated with membranes saturated with Dol-PP-(GlcNAc)2, 4dMan was incorporated into the first five mannose positions of the lipid-linked oligosaccharide (presumably those derived directly from GDP-Man). Dol-P-4dMan is unlikely to be a donor of 4dMan residues because the formation of lipid-linked oligosaccharides larger than the heptasaccharide was not observed (Fig. 4d) . In agreement with the observation that Dol-PP-(GlcNAc)2Man9 is formed in 4dMan-treated cells, large lipid-linked oligosaccharides were formed in vitro in the presence of GDP-Man and together (Fig. 4c) . It (Grier & Rasmussen, 1984) . The aqueous (4 mM-MgCl2) fraction was subjected to paper chromatography with solvent B. The radioactivity in 1 cm strips was measured by liquid-scintillation counting. (Grier & Rasmussen, 1983) . 4FMan was identified as the released product in each case after paper-chromatographic analysis with solvent B. + signifies that the sample was susceptible to the treatment used, and -signifies that the sample was resistant to the treatment used. Abbreviation: N.D., not determined. Distance migrated (cm) Fig. 7 . Analysis of the CM fraction after labelling BHK cells with 11-_4CI4FMan BHK 21 cells were labelled and extracted with CM as described in the legend to Fig. 6 . The CM extract was analysed by t.l.c. on silica gel G-60 with (a) solvent C, (b) solvent D, or (c) solvent E, and the radioactivity in 1 cm portions of each plate was measured by liquid-scintillation counting. The labelled material was eluted from the silica gel and adsorbed on DEAE-cellulose (acetate form) equilibrated with CMW. The label eluted with 2 mmammonium acetate in CMW was hydrolysed with acid under mild conditions and then subjected to paper chromatography with solvent B (d). The arrows indicate the positions of 1, Dol-P-Man, 2, solvent front, and 3, 4FMan.
Dol-P and a subsequent inhibition of lipid-linked oligosaccharide biosynthesis, as has been proposed for other sugar analogues (Schwarz & Datema, 1982a; McDowell et al., 1985 McDowell et al., , 1986 ). The observations that in vivo most glycoproteins synthesized in the presence of 4dMan are glycosylated and that a fully mannosylated dolichol intermediate is synthesized suggest that the trapping, if it is occurring, is only partial. The greatly diminished amounts of the fully glucosylated lipid-linked oligosaccharide indicate that Dol-P-Glc synthesis may be selectively impaired by 4dMan. In vitro it was found that GDP-4dMan more effectively inhibited Dol-P-Glc synthesis than it did that of Dol-P-Man (Table 2) . Taken together, the results obtained in vitro suggest that Dol-PGlc synthesis is inhibited in 4dMan-treated cells, perhaps through a decrease in Dol-P availability because of Dol-P-4dMan formation. As a result, the non-glucosylated intermediate Dol-PP-(GlcNAc)2Man9 is the predominant lipid-linked oligosaccharide synthesized in vivo.
It is not clear whether, in spite of the low steady-state amount of Dol-PP-(GlcNAc)2Man9Glc3, a sufficient amount of this intermediate is synthesized to glycosylate newly synthesized proteins. If so, then the inhibition of normal processing is most probably a consequence of incorporation of 4dMan residues into the oligosaccharides. An alternative explanation is that Mang-(GlcNAc)2 is transferred directly to the protein (Romero & Herscovics, 1986 ) and processed abnormally, either because of interference from incorporated 4dMan residues or because of impaired transport from the endoplasmic reticulum to the Golgi apparatus. It is also possible that 4dMan itself may be an inhibitor of the processing mannosidases. However, this remains to be tested.
It is interesting that two mannose analogues containing modifications at position C-4 can have such differing effects. Presumably the higher electronegativity of the fluorine atom in GDP-4FMan is responsible for its inhibitory effects, since GDP-4dMan is an alternative substrate. In a study of the glycosyltransferases involved in the biosynthesis of Salmonella 0-specific polysaccharides (Shibaev, 1978) it was found for GDP-Man that the 2-, 3-and 6-hydroxy groups of the D-mannosyl group do not participate in the interaction with the Salmonella mannosyltransferase. The effects of modification of the C-4 hydroxy group were not investigated with the Salmonella mannosyltransferase, but GDP-Man analogues containing 3-deoxy or 6-deoxy substituents are good substrates of the GDP-Man: Dol-P mannosyltransferase in chick-embryo cells (W. McDowell & R. T. Schwarz, unpublished work), indicating similarities between bacterial and avian mannosyltransferases. Thus it is possible that the C-4 position of mannose is an important determinant for enzyme-substrate recognition in mannosyltransferases. 
